CS
VERA icon

Candriam SCA’s Vera Therapeutics VERA Stock Holding History

Candriam SCA’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Buy
475,335
+25,781
+6% +$1.11M 0.1% 201
2025
Q4 		$22.8M Buy
449,554
+22,365
+5% +$794K 0.11% 176
2025
Q3 		$12.4M Buy
427,189
+130,248
+44% +$3.01M 0.07% 243
2025
Q2 		$7M Sell
296,941
-66,751
-18% -$1.5M 0.04% 304
2025
Q1 		$8.74M Sell
363,692
-2,307
-0.6% -$74.1K 0.05% 258
2024
Q4 		$15.5M Sell
365,999
-84,993
-19% -$3.76M 0.09% 202
2024
Q3 		$19.9M Buy
450,992
+157,232
+54% +$5.97M 0.11% 180
2024
Q2 		$10.6M Buy
293,760
+185,760
+172% +$7.37M 0.06% 246
2024
Q1 		$4.66M Buy
+108,000
New +$3.85M 0.03% 354

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return